STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [Form 3/A] BeOne Medicines Ltd. Amended Initial Statement of Beneficial Ownership

BeOne Medicines (ONC) amends Form 3 to add ADS holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3/A

Rhea-AI Filing Summary

BeOne Medicines Ltd. director Shalini Sharp filed an amended Form 3 to correct her initial insider holdings. The amendment now reflects ownership of 9 American Depositary Shares, held directly. A footnote explains that each ADS represents 13 Ordinary Shares. This update does not report any new buy or sell transactions; it simply adds ADS that were omitted from the original Form 3 and subsequent Forms 4, leaving all other previously reported information unchanged.

Positive

  • None.

Negative

  • None.
Insider Sharp Shalini
Role null
Type Security Shares Price Value
holding American Depositary Shares -- -- --
Holdings After Transaction: American Depositary Shares — 9 shares (Direct, null)
Footnotes (1)
  1. Each American Depositary Share represents 13 Ordinary Shares. This amendment reflects 9 American Depositary Shares that were omitted from the reporting person's original Form 3, and also were omitted from subsequent Forms 4 filed by the reporting person after the reporting person's original Form 3 was filed. All other information in the original Form 3 remains unchanged.
ADS holdings after amendment 9 American Depositary Shares Director’s direct ownership following Form 3/A
ADS to Ordinary ratio 1 ADS = 13 Ordinary Shares Relationship between ADS and Ordinary Shares
American Depositary Shares financial
"Each American Depositary Share represents 13 Ordinary Shares."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
Ordinary Shares financial
"Each American Depositary Share represents 13 Ordinary Shares."
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
Form 3 regulatory
"omitted from the reporting person's original Form 3, and also were omitted from subsequent Forms 4"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Form 4 regulatory
"and also were omitted from subsequent Forms 4 filed by the reporting person"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Sharp Shalini
(Last)(First)(Middle)
C/O BEONE MEDICINES I GMBH
AESCHENGRABEN 27, 21ST FLOOR
(Street)
BASEL4051
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
09/27/2024		3. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
10/02/2024
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares(1)9(2)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Each American Depositary Share represents 13 Ordinary Shares.
2. This amendment reflects 9 American Depositary Shares that were omitted from the reporting person's original Form 3, and also were omitted from subsequent Forms 4 filed by the reporting person after the reporting person's original Form 3 was filed. All other information in the original Form 3 remains unchanged.
Remarks:
/s/ Qing Nian, as Attorney-in-Fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did BeOne Medicines (ONC) disclose in this Form 3/A amendment?

BeOne Medicines director Shalini Sharp filed an amended Form 3 to correct her initial ownership. The amendment adds 9 American Depositary Shares that were previously omitted, while confirming all other information from the original Form 3 remains unchanged.

How many BeOne Medicines ADS does Shalini Sharp report owning now?

The amended Form 3 shows Shalini Sharp holding 9 American Depositary Shares of BeOne Medicines directly. This corrects an omission in the original Form 3 and subsequent Forms 4, updating her reported starting ownership position as a company director.

Does this BeOne Medicines Form 3/A amendment report any new insider trades?

The amendment does not report new insider trades. It simply updates the director’s reported holdings to include 9 American Depositary Shares that were omitted previously. Transaction fields show a holding entry rather than a buy or sell transaction.

What is the relationship between BeOne Medicines ADS and Ordinary Shares?

A footnote states that each BeOne Medicines American Depositary Share represents 13 Ordinary Shares. This means ADS provide indirect ownership in the company’s Ordinary Shares, packaged for trading in depositary receipt form on non-domestic markets.

Why was BeOne Medicines’ original Form 3 amended by Shalini Sharp?

The amendment was filed because 9 American Depositary Shares were omitted from Shalini Sharp’s original Form 3 and also from subsequent Forms 4. The Form 3/A corrects this oversight, while stating that all other original Form 3 information remains unchanged.